FICKENSCHER JAMES E (Chief Financial Officer) received a stock award from ZYNERBA PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 2/2/2023ACC: 0000899243-23-003726
Officer· Chief Financial Officer
Since Aug 2018
+15.15K
Net shares
Net buyer
$3.5K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
21.07K acquired · 5.93K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+21.07K
Price / share
—
Trade value
—
% of position
6.5%
1/31/2023
324.74K→345.81K
Common Stock
Direct
Shares
−5.93K
Price / share
$0.60
Trade value
$3.53K
% of position
1.7%
2/1/2023
345.81K→339.88K
Total
Net shares
+15.15K
Net value
-$3.53K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/31/2023 | A · Award | +21.07K | — | — | 6.5% | 324.74K | 345.81K |
| Common Stock Direct | 2/1/2023 | F · Tax Withholding | −5.93K | $0.60 | $3.53K | 1.7% | 345.81K | 339.88K |
| Total | +15.15K | -$3.53K | ||||||
Derivative Transactions0
No derivative transactions reported